Affiliation:
1. Département de Psychiatrie et d'addictologie, AP‐HP, GHU Paris Nord, DMU Neurosciences Hôpital Bichat ‐ Claude Bernard Paris France
2. Université Paris Cité NeuroDiderot, Inserm Paris France
3. Centre ChronoS GHU Paris ‐ Psychiatrie & Neurosciences Paris France
Abstract
AbstractIntroductionPsychomotor activity stands out as a crucial symptom in characterizing behaviors associated with depression. This study aims to explore the potential of actigraphy as a tool for digital phenotyping in characterizing symptoms of psychomotor agitation and retardation, which are clinically challenging dimensions to capture, in patients diagnosed with major depressive episode (MDE) according to DSM‐5 criteria.MethodsWe compared rest‐activity circadian rhythm biomarkers measured by the Motion Watch 8 actigraphy between 58 (78.4%) patients with MDE and psychomotor retardation (PMR), and 16 (21.6%) patients with MDE and psychomotor agitation (PMA), according to DSM‐5 criteria.ResultsActigraphy allowed to objectively report PMA through heightened activity over a 24‐h period, while PMR manifests as reduced activity during the most active 10 h. Lower rest‐activity rhythm (RAR) amplitude in PMR was accompanied by increased irregularities in intra‐ and inter‐day rhythms. Interestingly, actigraphy emerges as an objective tool to measure the characteristics of the active and rest periods, free from the confounding effects of sleep disturbances. Indeed, no differences in sleep disturbances were identified between patients exhibiting psychomotor agitation and those displaying PMR.ConclusionDigital phenotyping through actigraphy may aid in distinguishing psychomotor retardation and psychomotor agitation allowing for a more precise characterization of the depression phenotype. When integrated with clinical assessment, measurements from actigraphy could offer additional insights into activity rhythms alongside subjective assessments and hold the potential to augment existing clinical decision‐making processes in psychiatry.